New Clinical Data Show Dramatic Benefits of Femara for Women with Breast Cancer Even After Prolonged Period of No Anti-Cancer Treatment
13th Dec 2005, 14:42 GMT
- New data from MA-17 study showed Femara use led to 69 percent reduction in risk of breast cancer returning, even years after completing standard tamoxifen therapy
New Clinical Data Show Dramatic Benefits of Femara for Women with Breast Cancer Even After Prolonged Period of No Anti-Cancer Treatment related news:
- New clinical data shows dramatic benefits of Femara� for women with breast cancer even after prolonged period of no anti-cancer treatment — WebWire - Recent Headlines
- New Clinical Data Show Dramatic Benefits of Femara(R) for Women with Breast Cancer Even After Prolonged Period of No Anti-Cancer Treatment — PR Newswire: All Releases
- More good news - Femara helps prevent the return of breast cancer — News-Medical News Feed
- Aromatase inhibitor shows promise for breast cancer patients — The Cancer Blog
- Breast cancer treatment changing — The Cancer Blog
- Fatigue fairly uncommon after breast cancer chemo — RedOrbit News - Health
- Two Types Of Breast Cancer Treatments Show Similar Benefit — ScienceDaily Headlines: Health & Medicine
- Fatigue fairly uncommon after breast cancer chemo (Reuters) —
- Survival Benefit For Arimidex™ In Early Breast Cancer — Medical News Today RSS/XML Feed
- Long-term benefits for women with breast cancer who take letrozole — OnMedica Latest News